There are a variety of resources available for guidance on navigating contracts with pharmacy benefit managers, but you have to be cautious about whos supplying the information.
Increasingly, both private and public sector groups are beginning to take a careful look at the practices of pharmacy benefits managers as employers and taxpayers become curious about massive PBM profits and unclear contracts.
As state legislatures grappling with budget shortfalls search high and low for every possible angle to cut costs, big insurance companies and pharmacy benefit managers have managed to convince a handful of states to transition their Medicaid programs into a Managed Care model.
As Plavix loses its patent protection and Lipitor faces competition from multi-source generics, its an important time for consumers and benefits managers to understand how the transition from brand to generic will affect drug prices going forward.
DebugScreen: mobile
{
"author": {
"name": "Jason Wallace",
"webUrl": "/author/profile/jason-wallace/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 6,
"social": [],
"articles": [
{
"uri": "/2014/04/23/pharmacists-in-a-post-ppaca-world/",
"title": "Pharmacists in a post-PPACA world",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "April 23, 2014",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "Under PPACA, pharmacists are serving as a key health care provider, especially in rural communities.",
"body": null
},
{
"uri": "/2013/11/25/avoiding-misleading-pbm-contract-negotiation-guide/",
"title": "Avoiding misleading PBM contract negotiation guides",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "November 25, 2013",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "There are a variety of resources available for guidance on navigating contracts with pharmacy benefit managers, but you have to be cautious about whos supplying the information.",
"body": null
},
{
"uri": "/2013/10/17/exposing-pbms-spread-pricing-game/",
"title": "Exposing PBMs' spread pricing game",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "October 17, 2013",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "How do pharmacy benefit managers get away with this spread pricing, without most employers ever knowing?",
"body": null
},
{
"uri": "/2013/05/10/the-problem-with-mail-order-prescriptions/",
"title": "The problem with mail-order prescriptions",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "May 10, 2013",
"timeToRead": "2 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "Increasingly, both private and public sector groups are beginning to take a careful look at the practices of pharmacy benefits managers as employers and taxpayers become curious about massive PBM profits and unclear contracts.",
"body": null
},
{
"uri": "/2012/07/12/medicaid-managed-care-leaves-patients-and-pharmaci/",
"title": "Medicaid 'Managed Care' leaves patients and pharmacists on the outside",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "July 12, 2012",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "As state legislatures grappling with budget shortfalls search high and low for every possible angle to cut costs, big insurance companies and pharmacy benefit managers have managed to convince a handful of states to transition their Medicaid programs into a Managed Care model.",
"body": null
},
{
"uri": "/2012/06/18/june-marks-important-transition-for-brand-name-dru/",
"title": "June marks important transition for brand-name drugs",
"byline": "Jason Wallace",
"kicker": "",
"prettyDate": "June 18, 2012",
"timeToRead": "2 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jason-wallace/",
"name": "Jason Wallace"
}
],
"kickerNode": [],
"summary": "As Plavix loses its patent protection and Lipitor faces competition from multi-source generics, its an important time for consumers and benefits managers to understand how the transition from brand to generic will affect drug prices going forward.",
"body": null
}
]
}
}